The shares were picked up at an average price of Rs 4,680 apiece, taking the transaction value to Rs 300.32 crore.

Alkem bolsters its presence in dermatology and medical devices with the acquisition of Adroit Biomed and Bombay Ortho Industries. The move strengthens its portfolio in high-growth therapeutic segments ...

Samprada & Nanhamati Singh Family Trust sold 6,41,712 shares (0.54 percent stake) of Alkem Laboratories Ltd in a bulk deal at ...

The company's revenue from operations increased to Rs 3,374 crore in Q3 FY25, a marginal 1.5 per cent Y-o-Y rise from Rs 3,324 crore in Q3 FY24 ...

SBI Mutual Fund bought additional shares of Alkem Laboratories for Rs 300 crore, increasing its stake to 2.7%. The shares, totaling 6.41 lakh, were acquired at Rs 4,680 each. This transaction saw the ...

Mumbai: Cyber fraud has sent shockwaves through the pharma sector as Alkem Laboratories, a Mumbai-based pharmaceutical ...

At 09.16 am shares of Alkem Labs were trading at Rs 4,700.50 on the NSE. Alkem Labs shares are down over 16 percent ...

Nuvama cuts Alkem Lab's target price by 3.5% amid slow acute business; read more for insights on future projections.

Based on the one-year price targets offered by 17 analysts, the average target price for Alkem Laboratories Ltd (NSE:ALKEM) is $5726.05 with a high estimate of $7225.00 and a low estimate of $4330.00.

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an ...

SBI Mutual Fund acquired 0.54% stake in Alkem Laboratories for Rs 300 crore through open market transaction, increasing its ...